American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Organizations

Organizations

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Panacea Pharmaceuticals


Paragon Pharmaceutical Capital Llc


Pernix Therapeutics


Pfizer


Pharmaceutical Care Management Association


Portola Pharmaceuticals


Precision Advisors


Precision Bioservices


Precision for Medicine


Precision for Value


Prime Therapeutics Llc


Purdue Pharma L.p


Reckitt Benckiser Llc


Rite Aid


Salix Pharmaceuticals, Inc


Sandoz


Sandoz Inc.


Sanofi Us


Shire


Smith Drug Company


  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • »
Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Joe Grogan, Senior Fellow at USC Schaeffer

USC Schaeffer Center Senior Fellow on 340B: 'It's malpractice for Congress having a created a program that is totally out of control to not step in a fix this'

West Cuthbert, Senior Fellow, American Resolve Action

American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse'

Brian Blase, Ph.D., President of Paragon Health Institute

Paragon Health Institute links ACA and HRSA to 340B program growth, calls for reforms

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up